坪庭 直樹, 高橋 徹, 中村 吉宏, 宮川 康, 東田 章, 西村 憲二, 三浦 秀信, 辻村 晃, 松宮 清美, 奥山 明彦
2001 The Japanese Journal of Urology  
were va inated with 3T3 transfected with nee , a selecting marker , or vehicle alone , tumors were palpabLe by 13 days and lethal by 5weeks . In co コ trast, tumor growth was rctarded and survival was substantial ] y prolonged in mice vaccinated with 3T3 /PSMA or 3T3 / PSMAc 。 while PSMA − negative tumor growth was unaffected in these animals . Serum from mice va inatεd with either 3T3/ PSMA or 3T3 / PSMAc reacted with the human prostate cancer line LNCaP using immunohistochemical staining .
more » ... ical staining . 〈Conclusion>These results indicate that the 180 amino acid C − tenminal domain of PSMA may have pOtential for immunotherapy of prostate canceT . Prostate cancer lmmunotherapy PSMA
doi:10.5980/jpnjurol.92.370_1 fatcat:zqjgkitqvva7nppsiijk7ydffi